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ABSTRACT 
Objective: An amplitude growth function (AGF) shows the amplitude of an electrically evoked 
compound action potential (eCAP) as a function of the stimulation current. AGFs can be used to 
derive the eCAP threshold, which represents the minimum amount of current needed to elicit a 
measurable eCAP. eCAP thresholds have been widely used clinically to, for example, assist with 
sound processor programming. However, no eCAP precision has been included so far. The aim of this 
study was to investigate the precision of eCAP thresholds and determine whether they are precise 
enough for clinical use.  
Design: The study is retrospective and the data comprised 826 AGFs, intra-operatively measured in 
111 patients implanted with a HiRes90K cochlear implant (Advanced Bionics). For each AGF, the 
eCAP threshold was determined using two commonly used methods: linear extrapolation (LE) 
towards the x-axis and detection of the last visible eCAP (LV). Subsequently, the threshold 
confidence interval (TCI) of each eCAP threshold was calculated to serve as a metric for precision, 
whereby a larger TCI means a lower precision or reliability. Additionally, the eCAP thresholds results 
were compared to most recent behavioral fitting thresholds (T-profile) to put the eCAP threshold 
analysis in clinical context. Thereby, the association between eCAP and behavioral thresholds was 
calculated, both for all subjects together (group analysis) and, in contrast to previous studies, within 
individual subjects. 
Results: Our data show that the TCIs were larger with the LE method than with the LV method. The 
eCAP thresholds estimated by the LE method were systematically smaller than those estimated by 
the LV method, while the LE thresholds with the smallest TCIs correlated best with the LV thresholds. 
Correlation analysis between eCAP and behavioral thresholds revealed correlation coefficients of 
r = 0.44 and r = 0.54 for the group analysis of LE and LV thresholds, respectively. Within individual 
subjects, however, the correlation coefficients varied from approximately -1 to +1 for both LE and LV 
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thresholds. Further analysis showed that across subjects the behavioral thresholds fell within the 
TCIs of the eCAP threshold profiles. 
Conclusion: This study shows that eCAP thresholds have an uncertainty that can be estimated 
using TCIs. The size of the TCI depends on several factors, e.g., the threshold estimation method and 
measurement conditions, but it is often larger than one would expect when just looking at the 
threshold values. Given these large TCIs, future research on eCAP thresholds should be accompanied 
by a measure of precision to correctly apply eCAP thresholds in clinical practice. Comparing our eCAP 
threshold results with T-profiles indicates that the eCAP thresholds are possibly not precise enough 
to predict T-profiles. 
Keywords: Precision, Amplitude growth function; Cochlear implant; Electrically evoked compound 
action potential; Threshold; Fitting 
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INTRODUCTION 
The electrically evoked compound action potential (eCAP) of the auditory nerve can be 
measured using the telemetry function of a cochlear implant (CI). The eCAP is a synchronous 
response from multiple auditory nerve fibers evoked by electrical stimulation. An eCAP is typically 
recorded as a negative peak (N1) followed by a positive peak or plateau (P1). The amplitude of the 
response is measured from peak to peak and reaches values of several hundred microvolts (Abbas et 
al. 1999). Since the eCAP amplitude depends on the applied current, plotting the amplitude as 
function of stimulus level will result in an amplitude growth function (AGF) (Figure 1A). From this 
AGF, the eCAP threshold can be derived, representing the minimum amount of current needed to 
evoke a measurable neural response (Hughes 2013). These thresholds can be used to assist with 
sound processor programming predicting behavioral threshold levels (T-profiles) and maximum 
comfort levels (C/M-level). However, no clear correlations between eCAP thresholds and fitting 
levels have been found (Franck & Norton 2001; Franck 2002; Potts et al. 2007; Holstad et al. 2009). 
Possibly the mismatch between eCAP thresholds and T-profiles can be explained by an error analysis 
of eCAP thresholds. Two commonly used terms in error analysis are ‘accuracy’ and ‘precision’. 
Accuracy describes the difference between the estimated and the true value, whereas the precision 
describes the error around the estimated value.  Since the eCAP threshold is a (best) estimate, we do 
not know the true value, and the accuracy can hardly be determined. Therefore, the focus of this 
study is on the precision of the eCAP thresholds as derived using standard (clinical) methodologies 
and the consequences for clinical practice.  
Two methods are commonly used to estimate eCAP thresholds (Figure 1A). The simplest 
method is detection of the last visible eCAP (LV). This method tracks all recordings of the AGF from 
high to low current while detecting whether the recording still contains an eCAP. The current level 
where the eCAP was last visible is defined as the eCAP threshold. The LV threshold (green dot) of the 
AGF shown in Figure 1A is 200 clinical units (CU). Because eCAP amplitudes below noise level cannot 
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be detected, the LV threshold reflects the eCAP threshold at noise level. The second method is called 
linear extrapolation (LE). This method uses a linear regression line (Figure 1A, blue line) through data 
points representing a true neural response (black dots) to estimate the eCAP threshold at zero 
amplitude. The intercept of the line with the x-axis is defined as the eCAP threshold (blue dot at 
159 CU). In general, eCAP thresholds are determined automatically using smart algorithms followed 
by visual inspection by an expert (clinician, audiologist). Visual inspection is necessary to verify 
whether the algorithm has not been misguided by, for example, (stimulus) artefacts or noise. 
Moreover, one should be aware of bias (e.g., systematically over- or under-estimation of threshold) 
due to methodology or observer (Glassman & Hughes 2013; Akhoun et al. 2015). 
Thus far, AGFs have been measured without any precision analysis; eCAP amplitudes have been 
used as data points without measurement error (Figure 1A). However, the eCAP amplitude has a 
measurement error that can easily be included, and it would be worthwhile to include also a 
measure of the precision of eCAP thresholds. For example, the measurement error of the eCAP 
amplitude can be derived from a measurement without stimulation or from a section of the 
recording in which no neural response is expected (e.g., the last samples of the recording). In Figure 
1B the measurement error is added to the eCAP amplitude, as shown by the error bars. The method 
of threshold estimation itself also has uncertainty. Unfortunately, standard clinical AGFs do not 
contain the required information to calculate the measurement error of the eCAP threshold itself. 
Alternatively, we defined the threshold confidence interval (TCI) as a metric of threshold precision. 
The blue and green lines in Figure 1B show how the precision of the LE and LV methods can be 
determined and this is explained below in the methods section. 
The aim of this study was to investigate the precision of the eCAP threshold and the consequences 
on clinical practice. The study was retrospective and we made use of large dataset of eCAP recordings, 
which were measured regularly during surgery. Further, the LV and LE methods were evaluated as 
commonly done in the literature and clinic. The LV threshold was identified by a human observer rather 
than using an automated computer algorithm. The LE method was based on a linear fit towards the zero-
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intercept, though a non-linear fit or the intercept just above noise level would be better. To put the eCAP 
threshold precision in clinical context, we additionally compared the eCAP threshold analyses to 
behavioral T-profiles, and the association between both measures was calculated as well. To the best of 
our knowledge, this study is the first to perform this analysis for such a large population of CI recipients 
using an Advanced Bionics (AB) implant. In contrast to previous studies, the correlation analysis was not 
only performed for all subjects together (group analysis), but also within individual subjects. This makes 
present study one of the few studies examining the association between eCAP and behavioral thresholds 
within individual subjects (de Vos et al. in press). 
 
METHODS 
Patients and Data 
The AGFs used in this study originate from intra-operative eCAP measurements sequentially 
recorded in our hospital from January 2010 to December 2015. AGFs were available from 191 
patients. All patients were implanted with a HiRes90KTM device (Advanced Bionics, Sylmar, CA), 
either with a 1J or Mid-Scala electrode array, both consisting of 16 electrode contacts (1-16 in an 
apical to basal order). The AGFs were collected as part of our standard clinical eCAP recordings using 
forward masking and the Research Studies Platform Objective Measures (RSPOM) software from AB. 
This allowed us to compare the AGF data with the other eCAP recordings,  including spread of 
excitation (Biesheuvel et al. 2016) and refractoriness. The AGFs were measured on all odd electrode 
contacts using the following parameters: monopolar cathodic first biphasic pulses; pulse duration, 
32 µs/phase; masker probe interval, 400 µs; sweep rate, 25 Hz; masker offset, 0%; sampling rate, 
56 kHz; gain, 300; 32 averages; recording electrode two electrodes apical to stimulus (except 
electrode 1 where the recording electrode was two electrodes basal to the stimulus).  
The eCAP analysis was performed automatically by RSPOM using the default settings. Raw eCAP 
recordings were filtered using a low pass filter with a cut-off frequency of 8 kHz. Peak N1 was 
detected as the minimum over the time period between 180 and 490 µs and peak P1 as the 
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maximum between 470 and 980 µs after the end of stimulation. The eCAP amplitude was calculated 
as the peak-to-peak voltage between P1 and N1. After the automatic analysis, all peak detections and 
data points were verified. If necessary, corrections were made manually. In addition, the signal-to-
noise ratio (SNR) and measurement error of each eCAP were calculated using MATLAB (Mathworks, 
Inc., Natick, MA). The SNR of the eCAP was calculated as the eCAP amplitude divided by the noise 
amplitude, which in turn was defined as the maximal amplitude difference in the last 30 samples of 
the response. We assumed that no possible remaining artefact or neural response would occur over 
this section. The measurement error of the eCAP was set to the noise amplitude.  
The total batch of AGF measurements comprised AGFs measured with six and ten current steps. 
The functions with six current steps were measured when a full AGF with ten current steps could not 
be recorded due to time limitations during surgery. These six-point curves were measured in 56 
patients and were, unfortunately, not reliable enough for the purpose of this study. Therefore, only 
the ten-point AGFs, measured in 135 patients, were analyzed. Each AGF was visually inspected for 
inclusion; an AGF was included when at least one clear eCAP response was available and the AGF 
was not disrupted, such as due to a stimulus artefact. Finally, a total of 826 AGFs originating from a 
heterogenic group of 111 patients were included for further analysis (Table 1).  
To put the eCAP threshold analysis in clinical context, we additionally compared the eCAP 
threshold results with behavioral T-profiles. Most recent fitting thresholds were extracted from the 
SoundWave fitting software, assuming that these T-profiles were stable and most optimal. To ensure 
the reliability of the T-profiles, we only included profiles measured in subjects with an age above 4 
years, resulting in T-profiles from 73 subjects. The threshold levels were measured either for each 
electrode contact separately or by using streamlined programming (Plant et al. 2005). For these 
measurements we used tone bursts of biphasic pulse trains of 200 ms, as provided by the clinical 
speech program of the CI user. The measurement started at a subthreshold stimulus level and the 
level was increased until the patient heard the sound. After a clearly audible percept was achieved, 
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the stimulus level was decreased to reach a subthreshold level again. Subsequently the stimulus 
level was raised to find the final threshold level. The behavioral T-profiles were never set 
automatically using 10% of most comfortable level (optional in SoundWave). 
 
eCAP Thresholds and Precision 
The eCAP thresholds were calculated using a semi-automatic method programmed in MATLAB. 
The method automatically detects which recordings contain an eCAP using two conditions: the eCAP 
amplitude exceeds 20 µV and the SNR of the eCAP exceeds +13 dB Subsequently, all eCAPs and AGFs 
were visually inspected and, if necessary, corrections made manually.  
The LE method was based on a linear least square fit through all data points containing a neural 
response. Data points at the top of the AGF which clearly deviate from linear amplitude growth were 
excluded from the fit, as common in clinical practice. At least three data points were required 
because confidence intervals cannot be determined if the number or observations is equal to the 
number of coefficients. The precision of the LE threshold was calculated using the 95% confidence 
interval of the linear fit (Figure 1B, blue dashed line); there is a 95% probability that the true best-fit 
line for the AGF lies within this confidence interval. The confidence interval was extrapolated 
towards the x-axis in order to estimate the interval at zero-amplitude. For this purpose, the steepest 
and least steep linear fits within the confidence interval were calculated, and the intercepts of these 
lines with the x-axis were used to extrapolate the lower and upper boundaries of the confidence 
interval, respectively. Next, the distance between the two intercepts of the confidence interval with 
the x-axis was defined as the TCI. This TCI will be used as a measure of precision of the eCAP 
threshold estimated by the LE method. 
For the LV method, the eCAP threshold was set to the current level where the smallest true 
eCAP could be detected. This threshold can be found by tracking all recordings of the AGF from high 
to low current. The lowest current whereby an eCAP could be detected was defined as the eCAP 
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threshold. Estimating the precision of LV thresholds was less straight forward than with the LE 
method because the LV method does not have any mathematical clues. In our opinion, a good 
method was to use several guides as depicted in green in Figure 1B. The noise level (horizontal solid 
line) was estimated using data points not representing an eCAP (grey dots). Subsequently, a guide 
was drawn from the data point representing the LV (abscissa: 200 CU, ordinate: 68 µV) through the 
calculated noise level (abscissa: eCAP threshold minus one current step = 150 CU, ordinate: 38 µV). 
This guide (dashed line) represents the precision of the eCAP threshold towards the left side. If the 
noise level is zero, the size of the confidence interval at the left side of the threshold will be equal to 
the step size in current; the true zero-amplitude threshold will be between the estimate threshold 
and lower current. A high noise level, which is close to the smallest detectable eCAP amplitude, will 
result in a large(r) left confidence interval. Thus, due to the high noise level, it is uncertain where the 
zero-amplitude threshold exactly is. In addition, there is a high chance that the detected amplitude is 
not an eCAP, but still noise. In principle, the zero-amplitude threshold is at a lower current than the 
LV threshold and, consequently, the confidence interval at the right side could be set to zero. 
However, it is important to also include the eCAP measurement error, especially in cases in which 
the noise level is close to the smallest detectable eCAP amplitude. Therefore, the amplitude 
variation (error bar) in the last visible eCAP was translated into CU using a guideline between the last 
visible and next eCAP (solid green line). Projecting the top of the error bar on this guide led to the 
precision at the right side of the threshold, expressed in CU (vertical dashed line). Finally, the total 
TCI of LV thresholds was calculated as the distance between the two dashed lines at zero-amplitude. 
Importantly, the TCIs are not the true errors of the eCAP thresholds, but a best estimate of their 
precision.  
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Analysis 
When investigating the predictive value of eCAP thresholds for fitting behavioral levels, 
thresholds are frequently processed according to the method of Brown et al. (2000), matching the 
eCAP threshold profile with the T-profile using the threshold data at one electrode contact. This 
method overcomes the offset difference between the objective and subjective profiles induced by 
the effect that a small stimulus may be audible though the eCAP is still too small to measure. This 
method was applied in our study as well. It is important to realize that the study of Brown included 
Nucleus® patients in which the currents are presented along a logarithmic scale, while the 
HiRes90KTM as used in the present study applies linear current units. From a mathematical point of 
view, a scaling factor was required to replicate the shift as described by Brown. In addition, the 
scaling was also required to take the pulse width into account when comparing behavioral 
thresholds (measured in µA) to the objective thresholds (measured in CU). The profiles were 
matched on the electrode providing the least square error between the two profiles. 
Exploration of the TCI values estimated with the LE and LV methods revealed non-normally 
distributed TCI values and unequal variances for both methods. Therefore, the difference in TCI size 
between the two methods was investigated using Student’s t-tests for unequal variances in 
combination with a logarithmic transformation of the TCI values. Assuming that within the LE and LV 
methods the TCIs are equally distributed across the electrode array, we applied a linear mixed model 
to test the effect of electrode contact on the TCI size for each method separately. The model 
included electrode as fixed effect and subject as random effect. Straightforward correlation analysis 
was used to compare the eCAP thresholds obtained by the LE and LV methods.  
In addition, the association between eCAP thresholds for behavioral T-profiles was examined 
using a linear regression model. Pearson’s correlation coefficient was calculated within individual 
subjects as well as for all thresholds together (group analysis). Fisher’s z-transformation was used to 
11 
 
summarize the individual correlation coefficients and to enable further analyses on the correlation 
coefficients. 
  
RESULTS 
Figure 2 shows four illustrative examples of AGFs to demonstrate the effect of AGF morphology 
on the eCAP threshold and TCI. In panel A, the AGF measured at electrode 7 in patient S124 is 
shown. The AGF contains clear and large eCAPs, leading to a clear distinction of measurements 
containing an eCAP. Consequently, the TCI is small for both LE and LV methods, and the thresholds 
of both methods are close to each other. In Figure 2B, an AGF with much smaller eCAPs is shown. 
Because the eCAPs are closer to the noise level, it is more difficult to distinguish eCAPs from noise. 
Due to the lower SNR, the precision of eCAP amplitudes is less, resulting in a less reliable fit for the 
LE method and larger TCIs for both LE and LV methods. The examples in Figure 2A and 2C clearly 
show that an AGF is not necessarily linear; a shoulder near the noise level or a roll over at the top of 
the AGF was observed frequently. When data points at the top of the AGF clearly deviated from the 
linear amplitude growth, they were excluded from the linear fit (C), considerably improving the 
precision of the eCAP threshold. The AGF in panel D illustrates the effect of using a weighted linear 
fit (red) instead of the default normal fit (blue). The weighted fit took into account the measurement 
error of the eCAP amplitude. Consequently, the fit best reflects the most precise data points. In this 
example, weighting the measurement errors in the fit did not markedly affect the eCAP threshold 
itself, but the TCI became smaller. Finally, all AGFs were classified on eCAP amplitude to indicate 
how many AGFs will be represented by the examples shown. It turned out that 11% of the AGFs 
have an amplitude larger than 900 µV (A), 62% between 300 µV and 900 µV (C), 23% between 
150 µV and 300 µV (D) and 5% smaller than 150 µV (B). 
The boxplots in Figure 3 show the absolute TCIs grouped per electrode contact for the LE (A) 
and LV (B) methods. For each AGF, the absolute size of the confidence interval with respect to the 
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corresponding eCAP threshold was calculated separately for the left and right side. The intervals of 
all subjects were grouped per electrode contact and they are shown in boxplots. For visibility, the 
limits of the current-axis were set to -750 and 250 CU. Consequently, for the LE method thirteen 
outliers fell outside the axes limits of the figure: eleven on the left side (< -750 CU) and two on the 
right side (> 250 CU). For the LV method, all data points were within the axes limits. Comparing the 
TCIs of both methods revealed that the TCIs of the LE method were significantly larger at the 
contacts 3-15 (p < 0.005 for contact 5, p < 0.001 for all other contacts), while no difference in TCI size 
was found for the most apical contact 1 (p = 0.28). Further analysis of the effect of electrode contact 
on the TCI size revealed that for both the LE and LV methods the TCI is significantly larger (p < 0.001) 
at the base than at the apex. Across the electrode array, larger eCAP amplitudes were observed at 
the apex than at the base. 
In Figure 4A, the absolute difference between the LE and LV thresholds was plotted as a 
function of TCI size for the LE method. The LE thresholds are divided into four groups, each 
containing 25% of the sorted TCIs. The figure shows that the LV thresholds are larger than the 
corresponding LE thresholds and that the difference between the LV and LE threshold tends to 
increase with increasing TCI for the LE method. In addition, for each category, the LE thresholds 
were plotted against the LV thresholds using the same colors (Figure 4B). Significant correlations 
were found between the LE and LV thresholds for all groups (p < 0.001). The group with the most 
reliable LE threshold correlated best with the LV thresholds (r = 0.91 versus r = 0.71 for the most 
extreme pairs). 
 The scatterplots in Figure 5A and 5B show the relationship between eCAP thresholds and 
behavioral thresholds for the LE and the LV methods, respectively. Only subjects who had a 
complete eCAP threshold profile were included in the analysis. This resulted in 48 subjects for the LE 
method and 50 for the LV method, whereby only 5 subjects had an 1J array and the others a Mid-
Scalar. The thresholds are plotted in grey and the correlations within individual subjects are 
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illustrated by the black regression lines. Below the scatterplots, accompanying individual correlation 
coefficients are presented rank-ordered from low to high (panel C and D). The coefficients vary from 
-0.96 to 0.82 for the LE thresholds and from -0.81 to 0.92 for the LV thresholds. Mean individual 
Pearson’s correlation coefficients (calculated using Fisher’s z-transformation) for the LE and LV 
methods were r = 0.16 and r = 0.34, respectively. When analyzing all threshold values as one dataset, 
significant correlations were found between T-profiles and LE threshold profiles (p < 0.001, r = 0.44) 
and between T-profiles and LV threshold profiles (p < 0.001, r = 0.54). Additionally, Figure 6 
compares the behavioral thresholds with the eCAP thresholds and their TCIs. The TCIs are visualized 
as in Figure 3 but rotated 90 degrees clockwise. Remember from Figure 3 that the (normalized) eCAP 
thresholds are represented by the line at 0 CU. In panel A, the data are shown for the LE method 
(blue) and in panel B for the LV method (green). The behavioral thresholds (T, red) were plotted 
relative to the eCAP threshold profiles, showing the absolute difference between the eCAP and 
behavioral thresholds per electrode contact. Across all patients, the behavioral thresholds fell within 
the TCIs of the eCAP thresholds.   
 
DISCUSSION 
This study focuses on the precision of eCAP thresholds. In order to estimate precision, TCIs were 
assigned to eCAP thresholds estimated using the LE and LV method. eCAP thresholds estimated by 
the LE method were systematically smaller than the thresholds estimated by the LV method. The 
TCIs of the LE method were larger than those of the LV method, while the LE thresholds with the 
smallest TCIs correlated best with the LV threshold. Comparing the eCAP threshold profiles to 
optimally scaled T-profiles, we found that the T-profiles fell within the TCIs of the eCAP threshold 
profiles. This finding is one of the potential explanations why the literature provides mixed results 
for correlations between behavioral and objective profiles; the eCAP threshold precision is too low. 
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Correlation between eCAP and behavioral thresholds 
The correlation between eCAP thresholds and behavioral T- and C/M-levels has frequently been 
investigated to determine whether eCAP can be used to assist with sound processor programming 
and verify questionable behavioral responses. However, the outcomes have been moderate at best 
(Brown et al. 2000; Hughes et al. 2000; Franck & Norton 2001; Smoorenburg et al. 2002; Franck 
2002; Di Nardo et al. 2003; Polak et al. 2006; Potts et al. 2007; Holstad et al. 2009; Mittal & Panwar 
2009; Botros & Psarros 2010; Muhaimeed et al. 2010). There are several possible causes of the 
mismatch between objective and behavioral thresholds.  
First, there is an offset difference between behavioral and objective thresholds; a small stimulus 
may be audible though the eCAP is still too small to measure. This offset is patient-dependent and 
can even vary between electrode contacts, e.g., due to the electrode impedances. The difference 
between eCAP thresholds and behavioral levels can be reduced by matching the two profiles using 
the threshold data at one electrode contact (Brown et al. 2000), which was applied in this study as 
well. “Additionally, there are known variations, between clinics and brands, in the way T-profiles are 
set in clinical routine. Next to the commonly used 10% of M-level for AB recipients, there are various 
ways to determine the threshold levels (e.g., first hearing thresholds, counted thresholds, single-
electrode stimulation, interleaved bursts). Up till now, there has been no consensus which of these 
approaches lead to the best subjective map and should serve as the reference for eCAP-based 
fitting. The actual way of determining thresholds across the various studies using eCAP-based fittings 
is highly underreported (de Vos et al., in press), making it difficult to determine the best methods. 
Further, it is well known that pulse rate and duration of the stimulus affect both eCAP and 
behavioral thresholds, e.g., due to temporal integration (McKay et al. 2005; Lai & Dillier 2007; McKay 
et al. 2013; Hughes et al. 2014). Previous research found that the relationship between eCAP and 
behavioral thresholds becomes stronger when associated stimulation rates were equal or close to 
each other ((Brown et al. 1998; Franck & Norton 2001). However, equalizing the stimulation rates of 
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eCAP and behavioral measurements, routinely measured with single pulses (30 Hz) and pulse trains 
(>500 Hz) respectively, is not ideal. Lowering the stimulation rate for behavioral measurements 
makes the thresholds inadequate with respect to the high-rate speech strategy, while increasing the 
rate of eCAP measurements has a degrading effect on the quality and amplitude of the eCAP 
response (Charasse et al. 2004; Hughes et al. 2014). Therefore, the correlation between eCAP and 
behavioral thresholds is likely affected by differences in stimulation rate. This is probably also the 
case in this study. 
Because our study was retrospective, there were some non-ideal conditions for comparing the 
eCAP outcomes to behavioral data. First, there was a time lag between the intra-operative eCAP 
measurements and the T-profiles obtained from regular fitting sessions. We decided to use most 
recent T-profiles, because we assumed that these were stable and most optimal. However, because 
of physiologic changes within the cochlea in the first months after surgery (Hughes et al. 2001; 
Spivak et al. 2011), it is likely that the association between eCAP thresholds and T-profile presented 
in this paper is affected by the time lag between the two measurements. To evaluate this potential 
effect on our results, we re-analyzed the correlation using T-profiles from the first regular fitting 
after surgery, which were available in our SoundWave database as well. Using the Fisher r-to-z 
transformation, we tested whether the correlation changes if first fitting data (on average 2 months 
after surgery) was used instead of the most recent fitting profiles (on average 11 months after 
surgery). However, no significant differences were found, neither for all threshold data together (LE 
thresholds: p = 0.94, LV thresholds: p = 0.56) nor for the individual correlations (LE thresholds: 
p = 0.79, LV thresholds: p = 0.50).  
Further, our eCAPs were measured using RSPOM with the forward masking artifact rejection 
method, because they were a part of our clinical eCAP recording protocol. In contrast, eCAPs for 
fitting AB recipients will likely be measured via the clinical SoundWave software which by default 
uses alternating polarity. This difference in artefact rejection method potentially affects the clinical 
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applicability of our results as some studies observed an effect of method on the eCAP (Frijns et al. 
2002; Baudhuin et al. 2016). However, Hughes et al. (2016) thoroughly investigated the effect of 
artefact rejection on eCAP and they found no significant difference between forward masking and 
alternating  polarity for the amplitude and threshold of the eCAPs measured in AB recipients. For 
Cochlear devices, they conclude that the forward masking paradigm was even advantageous over 
alternating polarity. Lastly, the majority of the available AGF literature is based on the Cochlear 
system in which the forward masking technique is the default (de Vos et al. in press). Considering 
these aspects, we think that the effect of these measurement settings is negligible in light of the TCI 
size, the main topic of the study.  
Looking at the methods for calculating the correlation between objective and behavioral 
thresholds, only four studies perform correlation analysis on individual eCAP and T-profiles (Holstad 
et al. 2009; Franck 2002; Franck & Norton 2001; Potts et al. 2007) while the majority of the studies 
perform the analyses on grouped data (Brown et al. 2000; Cullington 2000; Smoorenburg et al. 2002; 
Di Nardo et al. 2003; Kiss et al. 2003; Morita et al. 2003; Kaplan-Neeman et al. 2004; Cafarelli Dees et 
al. 2005; King et al. 2006; Polak et al. 2006; Pedley et al. 2007; Lai et al. 2009; Mittal & Panwar 2009; 
Alvarez et al. 2010; Botros & Psarros 2010; Hughes & Stille 2010; Muhaimeed et al. 2010). However, 
group analysis does not provide any information about the correlation between profiles of individual 
subjects. The group correlation will be driven by the inter-patient variation, especially when the 
eCAP thresholds were matched to the T-profiles using one behavioral point (Brown et al. 2000; 
Smoorenburg et al. 2002; Willeboer & Smoorenburg 2006). Group analyses of our data revealed 
moderate correlation coefficients of r = 0.44 for T-profiles versus LE thresholds and r = 0.54 for 
T-profiles versus LV thresholds. Despite the non-ideal conditions for comparing eCAP and behavioral 
thresholds, these correlation coefficients were in accordance with other (large) studies in which the 
grouped correlation coefficient was calculated for T-profiles versus eCAP. Mittal & Panwar (2009) 
found r = 0.33 based on 90 subjects, Brown et al. (2000) found r = 0.55 with 44 subjects and 
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Muhaimeed et al. (2010) found r = 0.57 with 47 subjects. However, in order to examine the 
predictive value of eCAP thresholds for the fitting of individual subjects, it is preferable to compare 
the eCAP and behavioral thresholds for individual patients (de Vos et al. in press). Calculating the 
correlation within individuals resulted in correlation coefficients varying from strongly negative to 
strongly positive (Figure 5C and 5D). Compared to the three studies reporting within subject 
correlation coefficients, our results were comparable with these of Holstad et al. (2000). The study 
of Holstad reported coefficients ranging from -0.67 to 0.99 with a mean of 0.24. Note that these 
results were obtained in children using Cochlear devices. In the studies of Franck et al. (2001/2002) 
and Potts et al. (2007), the individual correlation coefficients ranged between 0 and +1. Together 
with the finding that the behavioral threshold levels fell within the (relative large) TCIs of the eCAP 
thresholds (Figure 6), these results indicate that the eCAP thresholds are possibly not precise enough 
to predict T-profiles at the level of individual subjects. 
 
eCAP Threshold Precision 
To the best of our knowledge, no study on eCAP thresholds has included error analysis for the 
eCAP amplitude. The data points of AGFs are commonly processed without error bar, and the 
estimated eCAP threshold is assumed to be good enough for application. However, to ensure that 
measurements are providing data that actually is clinical applicable its precision should be 
evaluated. For the LE method, eCAP amplitudes have a measurement error that can be used to 
improve the reliability of the linear fit. Data points with a small measurement error will have a 
higher weight, contributing more to the fit than points with a larger error. The effect of including the 
measurement error is shown in Figure 2D. Here, the TCI becomes smaller when a weighted linear fit 
is used. To investigate how a weighted fit influences the eCAP threshold and its TCI on group level, a 
correlation analysis was performed on both thresholds and TCIs estimated by LE and weighted LE. 
This post-hoc analysis revealed no significant difference between both LE and weighted LE 
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thresholds (p < 0.001, r = 0.99) and between corresponding TCIs (p < 0.001, r = 0.97). Nevertheless, 
including the measurement error increases the reliability of the eCAP threshold and TCI, because the 
weighted linear fit better reflects the measured data points.  
In addition, the goodness of fit (GOF) could be evaluated to estimate the reliability of the LE 
threshold. A worse fit would lead to a less reliable eCAP threshold and vice versa. Concerning the 
GOF, the question arose whether the linear fit is ideal, because we recurrently observed non-linear 
AGFs (e.g. Figure 2C). Therefore, we are working on a follow-up-study whereby we investigate the 
shape of the AGF and the GOF of several mathematical functions, e.g., a sigmoid fit (Ramekers et al. 
2014). Because the GOF is an indicator for the error of the linear fit (expressed as R2), it does not 
provide a valid measure of precision for the extrapolated threshold value (expressed in CU). 
Therefore, the TCI was developed to estimate the eCAP threshold precision in CU. Note, that the TCI 
is strongly associated with the GOF (p < 0.001, r = -0.79), because TCI of the LE method is based on 
95% confidence bounds which also is measure of GOF. 
It would be worthwhile to (re)consider what is actually measured by the LE and LV methods. For 
example, what kind of information is in an AGF, and how precisely can eCAPs and their thresholds be 
measured? Figure 4 shows that there is a systematic difference in the eCAP thresholds estimated by 
the two commonly used methods, thresholds estimated by LE being systematically lower than those 
estimated by the LV method. This difference can be explained by the fact that LE thresholds are 
estimated at zero-amplitude, where LV thresholds are estimated just above noise level. 
Consequently, the LV thresholds are probably overestimated compared to the real eCAP threshold. 
Furthermore, the success rate of the LV method is higher than that of LE. To estimate the eCAP 
threshold, one eCAP response is sufficient for the LV method, while at least two responses are 
required for the LE method. This explains why 48 subjects were included in Figure 5A compared to 
50 in 5B. To estimate threshold precision, one additional data point at a higher current is required 
for the LV method. For the LE method, at least three data points are required because the TCI 
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cannot be computed if the number of data points is equal to the number of coefficients in the linear 
fit. The size of the TCI considerably reduces when 4, or even more, data points are used. The step 
size or applied current scale affects the TCI as well, e.g., using a logarithmic current scale (Nucleus) 
would result in different TCIs than a linear scale (this study). When relatively large current steps are 
used, the LV threshold can be estimated less precisely, probably resulting in a larger overestimation 
of the threshold. In this study, a default step size of 50 CU was used, which was not ideal for the LV 
method. Generally, the LV method is performed with smaller current steps, especially around the 
threshold level (Botros et al. 2007; Glassman & Hughes 2013; Baudhuin et al. 2016). The use of 
smaller current steps in this study would have led to lower LV thresholds, and possibly smaller TCIs. 
The measure of how well the LV threshold represents the real eCAP threshold also depends on the 
noise level. The higher the noise level, the larger the eCAP must be to be visible and, in turn, the 
larger the deviation from the true eCAP threshold. Thus, when a measurement system has a 
relatively high noise floor, the LE method provides a better approximation of the eCAP threshold 
than the LV method. For our data, a mean systemic noise of 31.4 µV with a standard deviation of 
14.4 µV was found. Compared to other studies, this noise level is relatively high (Glassman & Hughes 
2013). Therefore, performing the analysis on an AGF measured by a CI with lower systemic noise 
would reduce the eCAP thresholds and TCIs, especially with the LV method. Finally, note that 
presented method of estimating eCAP precision using TCIs is generally applicable, but the presented 
quantities are specific for our data. Interpretation of eCAP thresholds and their precision should 
always be performed in light of the measurement conditions. Furthermore, the TCI reflects a best 
guess of the eCAP threshold precision rather than the true threshold error. In the follow-up-study, 
we want to investigate the error of the eCAP threshold induced by methodology or the random 
noise component as well. This error could be estimated using a varying number of averages or 
repeated measures. 
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In addition to Glassman et al. (2013), who already comprehensively compared the LE and LV 
methods, we wanted to highlight that the relationship between these two methods depends on the 
threshold precision. Figure 4 shows that the correlation between LE and LV thresholds is best if the 
TCI is small, originating from clear, i.e., relatively large eCAPs with a low measurement error (e.g. 
Figure 2A). Considering the points of the most precise thresholds (blue and red points), the 
correlation is close to that found by Glassman et al. (2013), suggesting that the eCAPs and AGFs used 
by Glassman et al. in their analysis were very clear. Additionally, we found that the TCIs were smaller 
at the apex than at the base of the cochlea, and that the TCIs of the LE and LV methods did not differ 
for the most apical electrode contact (Figure 3). This can be explained by the larger eCAPs at the 
apex than at the base of the cochlea. 
 
CONCLUSIONS 
This study showed that eCAP thresholds estimated by LE and LV have an uncertainty that can be 
estimated using TCIs as measure of precision. The size of the TCI depends on several factors, e.g. the 
threshold estimation method and measurement conditions, but it is often larger than one would 
expect when just looking at the threshold values. Given the relatively large TCIs, we recommend that 
future research on eCAP thresholds should be accompanied by a measure of precision to correctly 
apply eCAP thresholds in clinical practice. Comparing our eCAP outcomes with behavioral fitting 
levels, we found that the T-profiles fell within the TCI of the LE and LV thresholds. Further, although 
our conditions for comparing eCAP and behavioral thresholds were non-ideal, our findings were in 
line with the literature: significant correlations between the two parameters at the level of grouped 
data and correlation coefficients almost homogeneously ranging from -1 to +1 for individual 
subjects. Therefore, not only the relative large TCIs, but also the poor individual correlations of eCAP 
and behavioral thresholds indicate that the eCAP thresholds are possibly not precise enough to 
predict T-profiles. 
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FIGURE AND TABLE LEGENDS 
 
Figure 1. Example of an AGF shown as commonly used (A), and with additional information about 
the precision of eCAP and eCAP threshold (B). The AGF shows the eCAP amplitude as function of 
stimulus level, whereby corresponding eCAPs are shown at the right side, plotted from high (top) to 
low (bottom) stimulus level. Data points not representing true eCAPs are shown in grey and points 
reflecting eCAP responses (black) were used to estimate the eCAP thresholds for the LE (blue dot) 
and LV (green dot) methods. In (B), error bars are added reflecting the variation in eCAP amplitude. 
The guides were used to estimate the precision of the LE (blue) and LV (green) thresholds. AGF 
indicates amplitude growth function; eCAP, electrically evoked compound action potential; LE, linear 
extrapolation; LV, last visible.  
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Figure 2. Four examples of AGFs, illustrating different curve morphologies and their consequences 
for eCAP threshold and precision. The AGFs were plotted in the same way as in Figure 1. In addition, 
the LE method based on a weighted linear fit was drawn in panel D (red), while the LV threshold was 
omitted for the sake of visibility. AGF indicates amplitude growth function; LE, linear extrapolation; 
LV, last visible.  
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Figure 3. Illustration of the absolute TCI size (expressed in CU) across all subjects. The TCIs are 
grouped per electrode contact for the LE (A, blue) and LV (B, green) methods separately. Box 
boundaries represent the 25th and 75th percentiles, whiskers represent the most extreme data points 
not considered outliers, open circles represent outliers, and solid line within the box represent 
median. TCI indicates threshold confidence interval; LE, linear extrapolation; LV, last visible.  
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Figure 4. Difference between thresholds estimated using the LE and LV methods. The LE thresholds 
are sort from small to large TCI and divided in four groups, each group containing 25% of the AGFs 
(blue, red, green, purple). The left plot shows the absolute difference between LV and LE thresholds 
for each group separately. In the right panel a scatterplot between LV and LE thresholds is shown for 
the same groups. TCI indicates threshold confidence interval; LE, linear extrapolation; LV, last visible; 
AGF, amplitude growth function.  
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Figure 5. Scatterplots showing the correlation between eCAP thresholds (x-axis) and behavioral 
thresholds (y-axis) for the LE method (A) and the LV method (B). The thresholds are plotted in grey 
and the correlations within individual subjects are depicted by the black lines. Below the scatterplots 
(panel C and D), accompanying Pearson’s correlation coefficients were presented rank-ordered from 
low to high (black line). eCAP indicates electrically evoked compound action potential, LE, linear 
extrapolation; LV, last visible. 
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Figure 6. Comparison of the behavioral threshold profiles (T, red) with the objective eCAP thresholds 
and TCIs obtained with the LE (part A, blue) and LV (part B, green) methods. The eCAP thresholds 
and TCIs are presented as in Figure 3, whereby the (normalized) eCAP thresholds are represented by 
the line at 0 CU. The threshold values are grouped per electrode (horizontal) and expressed in CU 
(vertical). Box boundaries represent the 25th and 75th percentiles, whiskers represent the most 
extreme data points not considered outliers, open circles represent outliers, and solid line within the 
box represent median. eCAP indicates electrically evoked compound action potential, LE, linear 
extrapolation; LV, last visible. 
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Number of patients 111 
Gender (n)  
     Male 45 
     Female 66 
Implant type (n)  
     HiRes90K 1J 16 
     HiRes90K Mid-Scala 95 
Age (years)   
     Children (< 12) 38 
     Adults 73 
     Mean ± SD  39 ± 30 
Etiology (n)  
     Medication 1 
     Meniere  0 
     Meningitis 5 
     Otosclerosis 3 
     Trauma 3 
     Usher 3 
     Rubella 3 
     Congenital/Hereditary 37 
     Enlarged vestibular aqueduct 1 
     Cytomegalovirus 4 
     Other/Unknown 51 
  
Table 1. Patient demographics. 
